Cargando…
Post-COVID-19 interstitial lung disease presenting with profound hypoxemia: Report of three cases demonstrating a good response to high-dose corticosteroid therapy
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which leads to critical pneumonia, although the clinical courses vary. In some cases, COVID-19 pneumonia causes secondary pulmonary fibrosis, which can retain radiological changes and prolo...
Autores principales: | Uemasu, Kiyoshi, Yasuda, Yuto, Hirayama, Yutaka, Arasawa, Soichi, Iwashima, Daisuke, Takahashi, Ken-ichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598950/ https://www.ncbi.nlm.nih.gov/pubmed/34810106 http://dx.doi.org/10.1016/j.jiac.2021.11.010 |
Ejemplares similares
-
Efficacy of the combination of baricitinib, remdesivir, and dexamethasone in hypoxic adults with COVID-19: A retrospective study
por: Yasuda, Yuto, et al.
Publicado: (2022) -
Aluminium Gauze Reduces SARS-CoV-2 Viral Load in Non-Woven Masks Worn by Patients with COVID-19
por: Yasuda, Yuto, et al.
Publicado: (2022) -
Treatment with Sotrovimab and Casirivimab/Imdevimab Enhances Serum SARS-CoV-2 S Antibody Levels in Patients Infected with the SARS-CoV-2 Delta, Omicron BA.1, and BA.5 Variants
por: Fujimoto, Kana, et al.
Publicado: (2022) -
Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer
por: Kitaoka, Aya, et al.
Publicado: (2021) -
ENDEMIC IN THE PANDEMIC: MURINE TYPHUS MASKING AS COVID-19 PNEUMONIA WITH PROFOUND HYPOXEMIA
por: LAVERE, PHILIP, et al.
Publicado: (2021)